What is the fine-grained topic of the following text: This securities fraud class action lawsuit is brought against Valeant Pharmaceuticals International, Inc. for making false material statements: (a) deceived the investing public regarding Valeant’s prospects and business; (b) omitted disclosure of key aspects of the Valeant’s business, specifically its relationship with a network of specialty pharmacies utilized to boost sales of Valeant’s high-priced drugs; (c) Valeant’s undisclosed use of specialty pharmacies left it subject to increased regulatory risks that investors were unable to account for; (d) without use of specialty pharmacies, Valeant’s financial performance and financial guidance would have been negatively impacted. Only return the topic.
Securities fraud class action lawsuit against Valeant Pharmaceuticals International, Inc. for false statements and non-disclosure of business aspects